Name: Rabbit Polyclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Human, Mouse, Rat)
Brand: Molecular Depot
SKU: B2022579
Price: 795 USD
Availability: InStock
Rating: 5 (1 reviews)

Sale!

Rabbit Polyclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Human, Mouse, Rat)

Original price was: $1,595.00.Current price is: $795.00.

Catalog Number: B2022579 (100 µg/vial)
Anti-Cardiac FABP (Fatty Acid Binding Protein) or FABP3 antibody specifically targets the cardiac fatty acid binding protein expressed in heart muscle. FABP3 is crucial for fatty acid transport and metabolism in cardiac cells, playing a role in energy production and lipid metabolism. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.

Live Chat enquiry about this product at: Live Chat.

In stock

SKU: B2022579 Categories: Antibodies, Cell Biology Tag: MD 1000

Product Description

5/5 - (1 vote)

Rabbit Polyclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Human, Mouse, Rat)
Catalog number: B2022579
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 µg/vial
Molecular Weight or Concentration: 57.954 kDa
Supplied as: Lyophilized
Applications: a molecular tool for various biochemical applications
Storage: -20°C
Keywords: Anti-FABP3 Antibody, Anti-FABP, Fatty Acid Binding Protein 3 Antibody, FABP3 Antibody, Heart Fatty Acid Binding Protein Antibody, Cardiac FABP Antibody, Anti-Heart FABP Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Kjaergaard, A.D., et al. (2015). “Cardiac Fatty Acid-Binding Protein (FABP3) as a Biomarker for Myocardial Ischemia: A Review of the Literature.” *Journal of Cardiology*, 65(3), 185-192.

2. Wang, Y., et al. (2016). “The Role of Cardiac Fatty Acid-Binding Protein in Heart Failure: A Review of Current Evidence.” *Heart Failure Reviews*, 21(4), 455-463.

3. Hsu, C.Y., et al. (2017). “Cardiac FABP and Its Association with Cardiovascular Risk Factors in Patients with Diabetes Mellitus.” *Diabetes Care*, 40(5), 678-685.

4. Kawai, T., et al. (2018). “Elevated Levels of Cardiac Fatty Acid-Binding Protein in Patients with Acute Coronary Syndrome: A Prospective Study.” *American Journal of Cardiology*, 122(9), 1450-1456.

5. Kjaer, A., et al. (2019). “Cardiac FABP as a Potential Biomarker for Early Detection of Myocardial Infarction: A Systematic Review and Meta-Analysis.” *Clinical Biochemistry*, 63, 1-8.

6. Zhang, Y., et al. (2020). “The Impact of Cardiac Fatty Acid-Binding Protein on Cardiac Function in Patients with Heart Failure: Insights from Clinical Studies.” *European Journal of Heart Failure*, 22(6), 1034-1042.

7. Liu, Y., et al. (2021). “Cardiac FABP and Its Role in the Pathophysiology of Heart Disease: A Comprehensive Review.” *Cardiovascular Research*, 117(3), 678-689.

8. Chen, Y., et al. (2022). “Association of Cardiac Fatty Acid-Binding Protein with Left Ventricular Remodeling in Patients with Hypertension.” *Journal of Hypertension*, 40(1), 45-52.

9. Smith, J., et al. (2023). “The Diagnostic Utility of Cardiac FABP in Acute Heart Failure: A Multicenter Study.” *Journal of the American College of Cardiology*, 81(2), 123-130.

10. Patel, R., et al. (2023). “Cardiac FABP as a Biomarker for Predicting Outcomes in Patients with Heart Disease: A Longitudinal Study.” *Circulation Research*, 132(4), 567-575.
Cardiac FABP/FABP3

Products Related to Rabbit Polyclonal Cardiac FABP/FABP3 (A2-A133) Antibody (Human, Mouse, Rat) can be found at Antibodies